Targeting Semaphorin 3C in Prostate Cancer With Small Molecules

Despite the amenability of early-stage prostate cancer to surgery and radiation therapy, locally advanced and metastatic prostate cancer is clinically problematic. Chemical castration is often used as a first-line therapy for advanced disease, but progression to the castration-resistant prostate can...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Chung C W, Munuganti, Ravi Shashi Nayana, Peacock, James W, Dalal, Kush, Jiao, Ivy Z F, Shepherd, Ashley, Liu, Liangliang, Tam, Kevin J, Sedgwick, Colin G, Bhasin, Satyam, Lee, Kevin C K, Gooding, Luke, Vanderkruk, Benjamin, Tombe, Tabitha, Gong, Yifan, Gleave, Martin E, Cherkasov, Artem, Ong, Christopher J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2018
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280316/
https://www.ncbi.nlm.nih.gov/pubmed/30534631
http://dx.doi.org/10.1210/js.2018-00170

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280316/
https://www.ncbi.nlm.nih.gov/pubmed/30534631
http://dx.doi.org/10.1210/js.2018-00170

Ejemplares similares